Mad in America

DECEMBER 20, 2023

In Part 1 , we discussed Mad in America, the biopsychosocial model and the history of psychiatry. For Part 2, we will be covering reader questions on pharmaceutical marketing and issues with psychiatric treatments including psychiatric drugs and electroconvulsive therapy. Whitaker: Yes, these fit in hand in glove.

Pharmaceuticals 145

Pharmaceuticals Aging and mental health Hospitality Biopsychosocial model 145

Mad in America

DECEMBER 13, 2023

You sent some great questions and on this and our next podcast, we will be talking with Bob about Mad in America, the biopsychosocial model, the history of psychiatry, pharmaceutical marketing, and issues with psychiatric treatments including psychiatric drugs and electroconvulsive therapy. More aware of a need for humility.

Biopsychosocial model 141

Biopsychosocial model Pharmaceuticals Self-awareness Insurance 141

Mad in America

APRIL 30, 2025

When were you in medical school in the UK, were they teaching the DSM III disease model, or did you hear a different story about what causes depression? Moncrieff: When I was in medical school we were taught, as we’re still officially taught now, the biopsychosocial model of mental disorders.

Neurotransmitters and mental health 143

Neurotransmitters and mental health Pharmaceuticals Genetics and mental health Biopsychosocial model 143